Svoronos Dawn — SEC Form 4 filings
SEC reporting owner CIK 1574579. 9 Form 4 filings on record with FilingPulse; latest filed 2026-09-03.
Transaction summary — filings shown
Covers all 9 filings on record, filed 2024-06-05 to 2026-09-03. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 24.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Xenon Pharmaceuticals Inc. (XENE) | Director | 4 | — | — | 10 |
| Adverum Biotechnologies, Inc. (ADVM) | Director | 3 | — | — | 9 |
| ACELYRIN, Inc. (SLRN) | Director | 2 | — | — | 5 |
Form 4 filings — Svoronos Dawn
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-03 | 4 | Xenon Pharmaceuticals Inc. (XENE) | Option exercise (M): 5,144 @ $8.15 · Option exercise (M): 5,144 (derivative) @ $0 | EDGAR |
| 2026-06-03 | 4 | Xenon Pharmaceuticals Inc. (XENE) | Option exercise (M): 2,645 · Tax withholding (F): 1,416 @ $53.41 · Option exercise (M): 2,645 (derivative) @ $0 · Grant/award (A): 10,507 (derivative) @ $0 · Grant/award (A): 1,593 (derivative) @ $0 | EDGAR |
| 2025-12-10 | 4 | Adverum Biotechnologies, Inc. (ADVM) | Code (U): 5,000 · Disposition to issuer (D): 4,500 (derivative) · Disposition to issuer (D): 4,000 (derivative) · Disposition to issuer (D): 4,000 (derivative) · Disposition to issuer (D): 4,000 (derivative) · Disposition to issuer (D): 10,520 (derivative) · +1 more | EDGAR |
| 2025-06-20 | 4 | Adverum Biotechnologies, Inc. (ADVM) | Grant/award (A): 10,450 (derivative) @ $0 | EDGAR |
| 2025-06-06 | 4 | Xenon Pharmaceuticals Inc. (XENE) | Grant/award (A): 17,012 (derivative) @ $0 · Grant/award (A): 2,645 (derivative) @ $0 | EDGAR |
| 2025-05-23 | 4 | ACELYRIN, Inc. (SLRN) | Disposition to issuer (D): 15,000 · Disposition to issuer (D): 92,158 (derivative) · Disposition to issuer (D): 23,243 (derivative) · Disposition to issuer (D): 155,450 (derivative) | EDGAR |
| 2024-06-20 | 4 | Adverum Biotechnologies, Inc. (ADVM) | Grant/award (A): 10,520 (derivative) @ $0 | EDGAR |
| 2024-06-11 | 4 | ACELYRIN, Inc. (SLRN) | Grant/award (A): 92,158 (derivative) @ $0 | EDGAR |
| 2024-06-05 | 4 | Xenon Pharmaceuticals Inc. (XENE) | Grant/award (A): 15,542 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1574579 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →